Nicola Normanno

发表

KRAS, BRAF, PIK3CA, and PTEN mutations: implications for targeted therapies in metastatic colorectal cancer.

Sabine Tejpar, N. Normanno, F. Ciardiello, 2011, The Lancet. Oncology.

Management of metastatic colorectal cancer patients: guidelines of the Italian Medical Oncology Association (AIOM)

Francesca Valvo, Giuseppe Aprile, F. Valvo, 2017, ESMO Open.

Does the sequence of gemcitabine and vinorelbine affect their efficacy in non-small cell lung cancer in vitro?

C. Gridelli, N. Normanno, A. De Luca, 2004, Anticancer research.

Survival After Surgical Treatment of Lung Cancer Arising in the Population Exposed to Illegal Dumping of Toxic Waste in the Land of Fires ('Terra dei Fuochi') of Southern Italy.

Gaetano Rocco, Tonino Pedicini, Gerardo Botti, 2016, Anticancer research.

Implications for KRAS status and EGFR-targeted therapies in metastatic CRC

Sabine Tejpar, N. Normanno, F. Ciardiello, 2009, Nature Reviews Clinical Oncology.

Prognostic Applications of Gene Expression Signatures in Breast Cancer

N. Normanno, A. De Luca, P. Carotenuto, 2010, Oncology.

KRAS Early Testing: Consensus Initiative and Cost-Effectiveness Evaluation for Metastatic Colorectal Patients in an Italian Setting

L. Mantovani, N. Normanno, L. Capussotti, 2014, PloS one.

Guidance for laboratories performing molecular pathology for cancer patients

Etienne Rouleau, Manfred Dietel, Ed Schuuring, 2014, Journal of Clinical Pathology.

Integration of next-generation sequencing in clinical diagnostic molecular pathology laboratories for analysis of solid tumours; an expert opinion on behalf of IQN Path ASBL

Etienne Rouleau, Michael Hummel, Antonio Marchetti, 2016, Virchows Archiv.

The RAS/RAF/MEK/ERK and the PI3K/AKT signalling pathways: role in cancer pathogenesis and implications for therapeutic approaches

N. Normanno, A. De Luca, M. Maiello, 2012, Expert opinion on therapeutic targets.

Intratumor Heterogeneity of ALK-Rearrangements and Homogeneity of EGFR-Mutations in Mixed Lung Adenocarcinoma

Stefano Ferrero, Gaetano Rocco, Gerardo Botti, 2015, PloS one.

Epithelial to Mesenchymal Transition by TGFβ-1 Induction Increases Stemness Characteristics in Primary Non Small Cell Lung Cancer Cell Line

Gaetano Rocco, Virginia Tirino, Francesca Paino, 2011, PloS one.

Molecular diagnostics and personalized medicine in oncology: Challenges and opportunities

S. Costantini, N. Normanno, F. Fenizia, 2013, Journal of cellular biochemistry.

Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo.

Mohammad Zafari, Kevin P Williams, Ling Ling Chen, 2003, The Journal of clinical investigation.

Guide to detecting epidermal growth factor receptor (EGFR) mutations in ctDNA of patients with advanced non-small-cell lung cancer

N. Normanno, M. Denis, K. Thress, 2016, Oncotarget.

Gefitinib in Non Small Cell Lung Cancer

Gaetano Rocco, N. Normanno, J. Bryce, 2011, Journal of biomedicine & biotechnology.

Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis

David Salomon, N. Normanno, C. Bianco, 2005, Oncogene.